Literature DB >> 20837704

Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.

Chafen Lu1, Li-Zhi Mi, Michael J Grey, Jieqing Zhu, Elizabeth Graef, Shigeyuki Yokoyama, Timothy A Springer.   

Abstract

The mechanisms by which signals are transmitted across the plasma membrane to regulate signaling are largely unknown for receptors with single-pass transmembrane domains such as the epidermal growth factor receptor (EGFR). A crystal structure of the extracellular domain of EGFR dimerized by epidermal growth factor (EGF) reveals the extended, rod-like domain IV and a small, hydrophobic domain IV interface compatible with flexibility. The crystal structure and disulfide cross-linking suggest that the 7-residue linker between the extracellular and transmembrane domains is flexible. Disulfide cross-linking of the transmembrane domain shows that EGF stimulates only moderate association in the first two α-helical turns, in contrast to association throughout the membrane over five α-helical turns in glycophorin A and integrin. Furthermore, systematic mutagenesis to leucine and phenylalanine suggests that no specific transmembrane interfaces are required for EGFR kinase activation. These results suggest that linkage between ligand-induced dimerization and tyrosine kinase activation is much looser than was previously envisioned.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837704      PMCID: PMC2976375          DOI: 10.1128/MCB.00742-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.

Authors:  T Moriki; H Maruyama; I N Maruyama
Journal:  J Mol Biol       Date:  2001-08-31       Impact factor: 5.469

2.  The single transmembrane domains of ErbB receptors self-associate in cell membranes.

Authors:  Jeannine M Mendrola; Mitchell B Berger; Megan C King; Mark A Lemmon
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

3.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

4.  De novo prediction of three-dimensional structures for major protein families.

Authors:  Richard Bonneau; Charlie E M Strauss; Carol A Rohl; Dylan Chivian; Phillip Bradley; Lars Malmström; Tim Robertson; David Baker
Journal:  J Mol Biol       Date:  2002-09-06       Impact factor: 5.469

5.  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.

Authors:  Kathryn M Ferguson; Mitchell B Berger; Jeannine M Mendrola; Hyun Soo Cho; Daniel J Leahy; Mark A Lemmon
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

6.  Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor.

Authors:  K G Tanner; J Kyte
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

Review 7.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

8.  Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

Authors:  Hideo Ogiso; Ryuichiro Ishitani; Osamu Nureki; Shuya Fukai; Mari Yamanaka; Jae-Hoon Kim; Kazuki Saito; Ayako Sakamoto; Mio Inoue; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

9.  Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.

Authors:  Thomas P J Garrett; Neil M McKern; Meizhen Lou; Thomas C Elleman; Timothy E Adams; George O Lovrecz; Hong-Jian Zhu; Francesca Walker; Morry J Frenkel; Peter A Hoyne; Robert N Jorissen; Edouard C Nice; Antony W Burgess; Colin W Ward
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

Review 10.  An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.

Authors:  Antony W Burgess; Hyun-Soo Cho; Charles Eigenbrot; Kathryn M Ferguson; Thomas P J Garrett; Daniel J Leahy; Mark A Lemmon; Mark X Sliwkowski; Colin W Ward; Shigeyuki Yokoyama
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

View more
  94 in total

1.  Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.

Authors:  Rebecca A Scheck; Melissa A Lowder; Jacob S Appelbaum; Alanna Schepartz
Journal:  ACS Chem Biol       Date:  2012-06-05       Impact factor: 5.100

2.  Finding the missing links in EGFR.

Authors:  Nicholas J Bessman; Mark A Lemmon
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

3.  GxxxG motifs, phenylalanine, and cholesterol guide the self-association of transmembrane domains of ErbB2 receptors.

Authors:  Anupam Prakash; Lorant Janosi; Manolis Doxastakis
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

4.  Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.

Authors:  Sashikanth Banappagari; Miriam Corti; Seth Pincus; Seetharama Satyanarayanajois
Journal:  J Biomol Struct Dyn       Date:  2012-06-26

Review 5.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

6.  Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR.

Authors:  Julie K L Sinclair; Allison S Walker; Amy E Doerner; Alanna Schepartz
Journal:  Cell Chem Biol       Date:  2018-05-03       Impact factor: 8.116

7.  erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.

Authors:  Mara P Steinkamp; Shalini T Low-Nam; Shujie Yang; Keith A Lidke; Diane S Lidke; Bridget S Wilson
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

Review 8.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

9.  Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martínez-Salazar
Journal:  J Mol Model       Date:  2012-10-23       Impact factor: 1.810

10.  Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells.

Authors:  Mikkel Staberg; Christian Riemer; Ruodan Xu; Oksana Dmytriyeva; Elisabeth Bock; Vladimir Berezin
Journal:  Cell Oncol (Dordr)       Date:  2013-04-12       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.